NeurAxis's robust sales growth and disciplined cost management have set the stage for achieving cash flow breakeven in 2026. Notably, recent investments from life science-focused funds have bolstered ...

Some people diagnosed in UK and Europe with illness which begins with flu-like symptoms before a rash develops ...